97 drug makers including Han All under administrative measures.

According to the Yakup Press survey, about 226 drug companies were penalized with administrative measures during the first quarter of this year on account of the quality problems and no compliance of due labelling, including 2 month business suspension of Brolase tablet of Han All due to no compliance of supplemental data submission for its drug review and the Pfizer's Bextra on charge of prior...